Rakovina Therapeutics Balance Sheet Health
Financial Health criteria checks 3/6
Rakovina Therapeutics has a total shareholder equity of CA$2.9M and total debt of CA$1.4M, which brings its debt-to-equity ratio to 46%. Its total assets and total liabilities are CA$4.6M and CA$1.7M respectively.
Key information
46.0%
Debt to equity ratio
CA$1.35m
Debt
Interest coverage ratio | n/a |
Cash | CA$177.19k |
Equity | CA$2.94m |
Total liabilities | CA$1.67m |
Total assets | CA$4.61m |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: RKVT.F's short term assets (CA$226.8K) do not cover its short term liabilities (CA$314.0K).
Long Term Liabilities: RKVT.F's short term assets (CA$226.8K) do not cover its long term liabilities (CA$1.4M).
Debt to Equity History and Analysis
Debt Level: RKVT.F's net debt to equity ratio (40%) is considered satisfactory.
Reducing Debt: Insufficient data to determine if RKVT.F's debt to equity ratio has reduced over the past 5 years.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: RKVT.F has sufficient cash runway for 1 months based on last reported free cash flow, but has since raised additional capital.
Forecast Cash Runway: RKVT.F is forecast to have sufficient cash runway for 1 months based on free cash flow estimates, but has since raised additional capital.